![](/img/cover-not-exists.png)
A Phase 1 Study in Healthy Subjects to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Oral Doses of DS-2969b, a Novel GyrB Inhibitor
Vandell, Alexander G., Inoue, Satoshi, Dennie, Justin, Nagasawa, Yasuo, Gajee, Roohi, Pav, Joe, Zhang, George, Zamora, Cynthia, Masuda, Nobuhisa, Senaldi, GiorgioLanguage:
english
Journal:
Antimicrobial Agents and Chemotherapy
DOI:
10.1128/AAC.02537-17
Date:
February, 2018
File:
PDF, 474 KB
english, 2018